Herewith, the authors did not find any influence of etanercept (tumor necrosis factor inhibitor) treatment on depressive symptoms, which suggests the pathogenetic role of IL-17A in the development of depression in patients with psoriasis (37). Here, IL17A is linked to psoriasis.